产品编号 :
Cas No. :
CAS No. |
1415637-72-7 |
|---|---|
中文名称 |
PF-05085727(化合物代号;缺少结构性IUPAC系统命名,无法生成符合CCS的中文系统名) |
英文名称 |
PF-05085727 |
别名 |
PF-05085727;4-(AZETIDIN-1-YL)-1-METHYL-3-(1-METHYL-5-(4-(TRIFLUOROMETHYL)PHENYL)-1H-PYRAZOL-4-YL)-1H-PYRAZOLO[3,4-D]PYRIMIDINE;1H-Pyrazolo[3,4-d]pyrimidine, 4-(1-azetidinyl)-1-methyl-3-[1-methyl-5-[4-(trifluoromethyl)phenyl]-1H-pyrazol-4-yl]-;PF-05085727 >=98% (HPLC);PF05085727,PF 05085727 |
标准英文名 |
4-(azetidin-1-yl)-1-methyl-3-(1-methyl-5-(4-(trifluoromethyl)phenyl)-1H-pyrazol-4-yl)-1H-pyrazolo[3,4-d]pyrimidine |
分子式 |
C20H18F3N7 |
分子量 |
413.41 |
精确分子量 |
413.16 |
SMILES |
FC(C1=CC=C(C2=C(C3=NN(C)C4=NC=NC(N5CCC5)=C43)C=NN2C)C=C1)(F)F |
标准SMILES |
CN1N=CC(=C1C1C=CC(=CC=1)C(F)(F)F)C1=NN(C)C2=NC=NC(=C12)N1CCC1 |
用途 |
PF-05085727 is a potent, selective, and brain-penetrant inhibitor of cGMP-dependent PDE2A (IC50 = 2 nM), with >4000-fold selectivity over PDE1 and PDE3–11; it is used to study PDE2A-mediated biological processes and has potential applications in central nervous system disorders involving cGMP signaling. |
InChIKey |
SHAVEYUXRBIMLA-UHFFFAOYSA-N |
|
|
评论 |
|---|